Jyong Biotech Ltd.
MENS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001954488
No open-market purchases or sales by Jyong Biotech Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.01M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Jyong Biotech Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +2 vs. Q1 2026
- Shares held
- 488.1K
- +34.4K (+7.6%) vs. Q1 2026
- Total value
- $1.01M
- +$36.6K (+3.8%) vs. Q1 2026
- New holders
- 5
- 5 more added
- Sold out
- 3
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MENS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.01M |
| Q1 2026 | 17 | $974.0K |
| Q4 2025 | 19 | $2.73M |
| Q3 2025 | 8 | $4.15M |
| Q2 2025 | 2 | $781.2K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Jyong Biotech Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 9 | $19 | 0.00% | +9 | New |
| Bell Investment Advisors, Inc | 206 | $427 | 0.00% | −267−56.4% | Reduced |
| Cornerstone Financial Management LLC | 234 | $484 | 0.00% | +234 | New |
| Tower Research Capital LLC (TRC) | 1,070 | $2.21K | 0.00% | −10,633−90.9% | Reduced |
| GF Fund Management Co. Ltd. | 1,559 | $3.23K | 0.00% | −118−7.0% | Reduced |
| Citigroup Inc | 2,501 | $5.18K | 0.00% | −286−10.3% | Reduced |
| BNP Paribas Arbitrage, SA | 2,710 | $5.61K | 0.00% | +829+44.1% | Added |
| Mirae Asset Global Investments Co., Ltd. | 3,400 | $7.04K | 0.00% | −472−12.2% | Reduced |
| UBS Group AG | 4,046 | $8.38K | 0.00% | −33,317−89.2% | Reduced |
| JPMorgan Chase & Co | 5,379 | $11.8K | 0.00% | −300−5.3% | Reduced |
| Barclays PLC | 5,931 | $12.3K | 0.00% | +742+14.3% | Added |
| Morgan Stanley | 6,112 | $12.7K | 0.00% | −189−3.0% | Reduced |
| State of Wyoming | 11,208 | $23.2K | 0.00% | +11,208 | New |
| China Universal Asset Management Co., Ltd. | 12,100 | $25.0K | 0.00% | −1,073−8.1% | Reduced |
| Renaissance Technologies LLC | 22,900 | $47.4K | 0.00% | +22,900 | New |
| XTX Topco Ltd | 29,066 | $60.2K | 0.00% | +29,066 | New |
| HRT Financial LP | 50,423 | $104.0K | 0.00% | +38,656+328.5% | Added |
| Geode Capital Management, LLC | 68,882 | $142.6K | 0.00% | +4,650+7.2% | Added |
| BlackRock, Inc. | 260,317 | $538.9K | 0.00% | +1,557+0.6% | Added |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,590−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −13,927−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −266−100.0% | Sold out |